PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Worse Case, page-42

  1. 236 Posts.
    lightbulb Created with Sketch. 29
    paul rennie said he wants par to be a stock that one sits on patiently as he would rather a solid result over a longer period of testing and he also wants to not have to necessarily sell out to a big pharma too cheaply in the short term.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.